Plavix Injunction Ruling Will Include Irreparable Harm Interpretation
This article was originally published in The Pink Sheet Daily
Executive Summary
If a preliminary injunction is granted, Apotex says it would suffer irreparable harm of $4 bil.; Sanofi/Bristol counter it would be only $25 mil.
You may also be interested in...
Plavix "Irreparable Harm" Debated During Preliminary Injunction Appeal
Patent litigation case between Sanofi/Bristol and Apotex will follow in January.
Plavix "Irreparable Harm" Debated During Preliminary Injunction Appeal
Patent litigation case between Sanofi/Bristol and Apotex will follow in January.
Plavix Generic Faces Injunction, But Not Recall
Apotex is filing emergency appeal to stay the injunction after Bristol and Sanofi win in U.S. district court.